Michael Luciani highlighted a notable investment trend, stating that over half of climate tech funding has gone into energy and transport, while industrials and agriculture—the major pollution contributors—receive less attention.
Luciani emphasized the potential of engineered biology in addressing the major climate challenges, asserting it could be the solution for sectors like manufacturing, agriculture, and building construction.
Kan illustrated Juniper's evolution, explaining that after their early focus on synthetic biology, they recognized the need to strengthen their identity as the 'climate biotech people', moving beyond a generalist approach.
Their inaugural fund, attracting $10.6 million, is oversubscribed, with backing from diverse stakeholders including family offices, scientific investors, and veteran venture capitalists, showcasing solid market confidence.
Collection
[
|
...
]